What is the role of circulating IGF-I?

Trends in Endocrinology and Metabolism

Volumn 12, Issue 2, 2001, Pages 48-52

  Le Roith, Derek ^a   Scavo, Louis ^a   Butler, Andrew ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN C;

ANIMAL; ANIMAL MODEL; GENE DELETION; GENETICS; GROWTH; HUMAN; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW;

ANIMALS; GENE DELETION; GROWTH; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; SOMATOMEDINS;

EID: 0035286172     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1043-2760(00)00349-0     Document Type: Review

References (48)

1. Keller, G. and Snodgrass, H.R. (1999) Human embryonic stem cells: the future is now. Nat. Med. 5, 151-152
2. Choi, K. et al. (1998) A common precursor for hematopoietic and endothelial cells. Development 125, 725-732
3. Bach, S.P. et al. (2000) Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21: 469-476
4. Kano, J. et al. (2000) The in vitro differentiating capacity of nonparenchymal epithelial cells derived from adult porcine livers. Am. J. Pathol. 156, 2033-2043
5. Pittenger, M.F. et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147
6. Jacobson, M.D. et al. (1997) Programmed cell death in animal development. Cell 88, 347-354
7. Laron, Z. (1993) An update on Laron syndrome. Arch. Dis. Child 68, 345-346
8. Takahashi, Y. et al. (1996) Brief report: short stature caused by a mutant growth hormone. New Engl. J. Med. 334, 432-436
9. Gluckman, P.D. et al. (1981) The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr. Rev. 2, 363-395
10. Daughaday, W.H. and Rotwein, P (1989) Insulinlike growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10, 68-91
11. Sonksen, PH. et al. (1991) Metabolic effects of hypopituitarism and acromegaly Horm. Res. 36, 27-31
12. Wang, J. et al. (1999) Igfl promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J. 13, 1985-1990
13. Liu, J.L. et al. (1998) Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol. Endocrinol. 12, 1452-1462
14. Liu, J.L. and Le RoithD. (1999) Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140, 5178-5184
15. Kopchick, J.J. et al. (1999) Transgenic models of growth hormone action. Annu. Rev. Nutr. 19, 437-461
16. Dominici, F.P. et al. (1999) Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. Am. J. Physiol. 277, E447-E454
17. Froesch, E.R. et al. (1996) Insulin-like growth factor I: physiology, metabolic effects and clinical uses. Diabetes Metab. Rev. 12, 195-215
18. Ekberg, S. et al. (1989) Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver Endocrinology 125, 2158-2166
19. Bezecny, I. et al. (1992) Growth hormone treatment increases oestrogen receptor concentration in the guinea-pig uterus. J. Endocrinol. 134, 5-9
20. Li, H. et al. (1998) Growth hormone and insulinlike growth factor I induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation? Endocrinology 139, 3855-3862
21. Roberts, C.T. et al. (1987) Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol. Endocrinol. 1, 243-248
22. Powell-Braxton, L. et al. (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev. 7, 2609-2617
23. Liu, J.P. et al. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1IGF receptor (Igf1r). Cell 75, 59-72
24. Murphy, L.J. et al. (1987) Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol. Endocrinol. 1, 445-450
25. Hatey F et al. (1992) Gonadotropins induce accumulation of insulin-like growth factor I mRN A in pig granulosa cells in vitro. Mol. Cell. Endocrinol. 86, 205-211
26. Hussain, M.A. et al. (1993) Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J. Clin. Invest. 92, 2249-2256
27. D'Ercole, A.J. et al. (1980) Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev. Biol. 75, 315-328
28. Bell, G.I. et al. (1990) Sequence of a cDNA encoding guinea pig IGF-I. Nucleic Acids Res. 18, 4275
29. Casella, S.J. et al. (1987) Isolation of rat testis cDNAs encoding an insulin-like growth factor I precursor. DNA 6, 325-330
30. Jansen.M. et al. (1983) Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 306, 609-611
31. Garland, J.T. et al. (1972) Stimulation of DNA synthesis in isolated chondrocytes by sulfation factor. Endocrinology 90, 1086-1090
32. D'Ercole, A.J. et al. (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. U. S. A. 81, 935-939
33. Isaksson, O.G. et al. (1982) Growth hormone stimulates longitudinal bone growth directly. Science 216, 1237-1239
34. Isgaard, J. et al. (1988) Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology 122, 1515-1520
35. Schlechter, N.L. et al. (1986) Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc. Natl. Acad. Sci. U. S. A. 83, 7932-7934
36. Shalet, SM. et al. (1979) Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J. Pediatr. 94, 719-722
37. Hoffenberg, R. et al. (1977) Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone. Clin. Endocrinol. 6, 443-448
38. Gu, H. et al. (1994) Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106
39. Sauer, B. (1993) Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225, 890-900
40. Yakar, S. et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 96, 7324-7329
41. Sjogren, K. et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. U. S. A. 96, 7088-7092
42. Villafuerte, B.C. et al. (1996) Insulin and insulinlike growth factor-I regulate hepatic insulin-like growth factor binding protein-3 by different mechanisms. Mol. Endocrinol. 10, 622-630
43. Villafuerte, B.C. et al. (1994) Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology 134, 2044-2050
44. Martin, J. and Baxter, R. (1999) IGF binding proteins as modulators of IGF action. In Contemporary Endocrinlogy: The IGF System (Rosenfeld, R.G. and Roberts, C.T., Jr, eds), pp. 227-256, Humana Press
45. Powell, D.R. et al. (1991) Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J. Biol. Chem. 266, 18868-18876
46. Powell, D.R. et al. (1993) Multihormonal regulation of IGFBP-1 promoter activity. Adv. Exp. Med. Biol. 343, 205-214
47. Zarandi, M. et al. (1994) Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc. Natl. Acad. Sci. U. S. A. 91, 12298-12302
48. Kovacs, M. et al. (1996) Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action. Endocrinology 137, 5364-5369